This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
The FDA put a black-box warning on the treatment after receiving 11 reports of T-cell lymphomas in patients receiving it, but new research says the risk is low.
However, the FDA said the benefits of the treatment still outweigh the risks.
CAR T therapies are currently used to treat blood cancers, including multiple myelomas, leukemias, and B-cell lymphomas.
